*Refresh the page if the below document does not appear.
Central Drugs Standard Control Organization has joined hands with the concerned state regulatory bodies to investigate upon the information shared by WHO. The cough and cold syrups manufactured by Maiden Pharmaceuticals is allegedly responsible for the death of 66 Children in the Gambia.
Glenmark Pharma announced that it has become India’s first company to launch Thiazolidinedione Lobeglitazone for Type 2 DM in Adults. In addition, Indians have a high number of Type 2 diabetes patients who have “insulin resistance” for which their drug LOBG is a good option.
The use of unethical means to promote a brand is against the Uniform Code for Pharmaceutical Marketing Practices that is responsible for regulation of marketing. But unlike Doctor’s Hippocratic Oath, it is voluntary and thus occassionally exploited by Pharma industries.
DCA (Drug Control Administration) drew five samples of liquid formulations manufactured using ethylene glycol from Maiden Pharmaceuticals Baddi unit as a precautionary measure after its Sonipat facility’s ‘substandard’ formulations killed 66 children in Gambia.
The Delhi-based Pharma Company Maiden Pharmaceuticals over the counter painkiller drug and Type-2 Diabetes Prescription drug were found to be ‘substandard’ quality during lab tests in Kerela, that too almost five times in the last nine months.
Zydus was the first applicant to file a substantially complete Abbreviated New Drug Application with a paragraph IV certification. It has received a final nod from US regulatory authority to manufacture and market Brivaracetam tablets USP 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg.
The company has announced the kick-off of
two Chlorantraniliprole (CTPR) pesticide
formulated combination products with the
brand names NATVOL (CTPR 8.8% +
Thiamethoxam 17.5% SC); and NATLIGO
(CTPR 9.3% + Lambda-cyhalothrin 4.6% ZC).
Please update your profile to keep using the website